Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GSK1904529A (2 h) inhibits phosphorylation of IGF-IR and IR with IC50s of 22 and 19 nM in NIH-3T3/LISN and NIH-3T3-hIR cells
The expression of Wnt-target genes (AXIN2
Drug Intell Clin Pharm
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
CAS Number: 1046787-18-1
Vicriviroc Malate R)-Bicalutamide GSK1904529A (2 h) inhibits phosphorylationVicriviroc, also known as SCH 417690, MK 7690 and SCH D, is a potent, orally active and selective CCR5 entry inhibitor of HIV 1 (IC50 = 0. 91 nM). Vicriviroc effectively inhibits the initial stages of the virus life cycle. Vicriviroc demonstrated synergistic anti HIV activity in combination with drugs from all other classes of approved antiretrovirals. Vicriviroc binds with higher affinity to CCR5 than SCH C. Functional assays, including inhibition of
US$ 38.00
US$ 38.00
US$ 120.00
US$ 36.00
US$ 125.00
US$ 38.00
US$ 38.00
US$ 50.00
US$ 68.00
US$ 120.00
US$ 65.00
US$ 88.00
US$ 100.00
US$ 38.00